http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-992384-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ae95e7759e7ecd9a4ab7f46795c1ce3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-52
filingDate 1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09645406530f959c95fe5bfe58e9b69f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_452487fb37949a8fffe9548ded210a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe1bff43d30eabd736345b15932a953
publicationDate 1999-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-992384-L
titleOfInvention Multivalent salts of pyridostigmine and related compounds
abstract A quaternary ammonium cholinergic agent is complexed with a multivalent anion or with the multiple monovalent anion. The complex can be administered orally to a patient to treat pain or for other purposes. A variety of modifications may be appropriate, including modifications to the ring's ring structure, as well as ring substitution and functionalization. Other relevant modifications include the use of various anions, including different monovalent and polyvalent anions, and both organic and inorganic anions. The compounds have use as cholinergic agents, especially in the treatment of myasthenia grayish, chest pain and carpal tunnel syndrome.
priorityDate 1996-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506067

Total number of triples: 34.